SHR-4849

SHR-4849 · Suzhou Suncadia Biopharmaceuticals Co., Ltd.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for SHR-4849, covering 2025-03-05 to 2026-03-03. Get the full timeline:

Most recent: Clinical Trial Update: A Trial of SHR-4849 Combined With Other Antitumor Drugs in Patients With Malignant Solid Tumors [Phase 2]